Platinum Management Buys More Echo Therapeutics Inc (ECTE) Shares

Platinum Management, managed by Mark A. Nordlicht, has acquired 16,961 shares of Echo Therapeutics Inc (NASDAQ:ECTE), a new filing with the U.S. Securities and Exchange Commission showed. The shares were purchased in multiple transactions for a purchase price of $2.2 apiece. Currently, Platinum owns 1.61 million shares, up from 578,452 shares disclosed previously.

Echo Therapeutics Inc (ECTE)

In December 2013, Platinum Management reported upping its stake in Echo Therapeutics Inc (NASDAQ:ECTE) to 578,452 shares. Echo Therapeutics Inc (NASDAQ:ECTE) is a medical device company developing its Symphony CGM System as a non-invasive, wireless continuous glucose monitoring system. The company has a market cap of $26.7 million.

Last week, Echo Therapeutics Inc. (NASDAQ: ECTE) announced that the company’s stockholders elected Shepard M. Goldberg as a new member of the company’s board of directors at the 2014 annual meeting of stockholders held June 19, 2014.

For the first quarter of 2014, the company reported net loss for of $2.8 million, or $0.23 per share, compared to $7.0 million, or $1.30 per share, for the first quarter of 2013. The operating loss for the quarter was $2.7 million compared to $5.5 million for the first quarter of 2013. Research and development expenses decreased by $2.1 million, or 64%, to $1.1 million for the first quarter, compared to $3.2 million for the first quarter of 2013, according to a statement.

On Wednesday, Echo Therapeutics Inc (NASDAQ:ECTE)’s stock gained 0.90% to $2.23. It has a 52 week high of $4.91 and a 52 week low of $1.53. The consensus average target price for the stock is $2.00, and the consensus average recommendation is ‘Hold.’

Other largest shareholders of Echo Therapeutics Inc (NASDAQ:ECTE) include Fred Knoll’s Knoll Capital Managementm, which holds 28,630 shares, Jim Simons’ Renaissance Technologies, which revealed ownership of 40,787 shares of the company.

Total value of Platinum Management’s equity portfolio totaled $211.71 million as of the end of the first quarter of 2014. In term of value, Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) was the largest holding, in which the fund owns 14.07 million shares. It is followed by NXP Semiconductors NV (NASDAQ:NXPI), in which the fund holds 168,000 shares.

Disclosure: none

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!